Audio By Carbonatix
BioMex, in collaboration with the German Development Cooperation, has opened applications for the Cohort 2 BioMex Certificate Programme, a fully funded, internationally recognised upskilling programme.
Professionals, recent graduates and aspiring innovators in biotechnology, pharmaceutical sciences, health care and life sciences in Ghana are invited to take the next step in advancing their careers as applications close on July 10, 2026.
Delivered in collaboration with the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH’s Strengthening the Ghana Pharma Sector Focusing on Vaccine Production (PharmaVax Ghana), the BioMex Certificate Programme offers participants a unique opportunity to upskill through a flexible and tailor-made selection of 26 modules across 6 thematic competence clusters.
The programme allows individuals to select modules tailored to their professional goals and add to their existing skill set to get ahead in their careers.
The thematic clusters cover Biotechnology & Biomedicine, Pharmaceutical Chemistry & Pharmaceutical Technology, Innovation Management and Intercultural Cooperation, Facility, Energy and Environmental Management, Health Care and Smart Medical Technologies, as well as Compliance and Risk Assessment.
Successful applicants to the BioMex Certificate Programme will benefit from a fully funded participation model; an individual, tailor-made module selection aligned with career goals; an internationally recognised certificate and access to the international BioMex alumni network.
Interested candidates are encouraged to apply before the July 10 deadline. Application requirements include a CV, university degree, transcript of records with overall grade, grading scale, letter of motivation, and one letter of reference.
The BioMex Certificate Programme is working with the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH through the PharmaVax Ghana programme, which is co-funded by the European Union and the German Federal Ministry for Economic Cooperation and Development.
It is part of the Team Europe Initiative Manufacturing and Access to Vaccines, Medicines and Health Technologies in Africa (MAV+).
Further information and application details are available at:
Latest Stories
-
Government backs independent commission to determine Article 71 office holders’ salaries
5 minutes -
MobileMoney Fintech LTDrewards top drivers and riders in “Ride with MoMo” Promo
15 minutes -
In Photos: Mfantsipim marks 150th anniversary with second sesquicentennial lecture
19 minutes -
Mahama establishes GH¢1m trust funds for children of helicopter crash victim
25 minutes -
Government accepts abolition of death penalty, proposes life imprisonment for capital offences
35 minutes -
Sedina Tamakloe’s appeal began under my predecessor, I opposed it after review – AG
37 minutes -
Government backs presidential tax on salary and allowances, rejects taxing ex gratia and pension
41 minutes -
Mahama honours families of helicopter crash victims with legacy letters and support package
42 minutes -
Government backs citizen-led constitutional amendments with 10% voter support threshold
43 minutes -
Proposed five-year presidential term will not apply to Mahama – Felix Kwakye Ofosu
45 minutes -
Sedina Tamakloe-Attionu acquittal raises corruption fight concerns – John Darko
46 minutes -
Education is Ghana’s strongest long-term weapon against corruption – Ibn Chambas
48 minutes -
No democracy can flourish where corruption becomes normalised — Ibn Chambas
1 hour -
Nicaraguan leader proposes extending presidential term by another year
2 hours -
Gov’t accepts constitutional amendment for equal voting rights in political party primaries
2 hours